ADAP

Adaptimmune Therapeutics plc American Depositary Shares

$7.37 -$0.08 -1.09%



Shares Bought2
Shares Sold2
Total4
Shares Owned0
Last Price$7.37
Total Return$0.15
Range Today$7.22 - $7.50
52 Week Range$3.76 - $9.29
Open$7.48
Market Cap$697.96M
Volume/Average165.36K/253.53K
P/E Ratio-
Dividend/Yield-




Adaptimmune Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin on December 3, 2014 and is headquartered in Abingdon, the United Kingdom.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
11-01-17 15:23 11-02-17 17:53 $7.69 $7.69 +$0.00 +0.00% genovahero
08-28-17 15:18 08-28-17 19:26 $5.84 $5.99 +$0.15 +2.57% crizisaround pissedoffghost